Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Lukang Pharmaceutical is a strategic subsidiary of the Shandong Lukang Pharmaceutical Group, one of China's largest and most established pharmaceutical manufacturers. Based in Hangzhou, the company primarily functions as a major distribution and wholesale hub for the group's extensive portfolio of anti-infective agents and chemical drugs. Its product range includes essential antibiotics such as penicillins, cephalosporins, and various semi-synthetic derivatives, as well as veterinary medicines and pharmaceutical intermediates. By leveraging the parent company's massive fermentation and chemical synthesis capabilities, Zhejiang Lukang facilitates the supply of high-quality active pharmaceutical ingredients (APIs) and finished dosages to both domestic and international markets. The company plays a critical role in the group's commercial operations, ensuring the broad availability of life-saving anti-infective treatments across the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Lukang Pharmaceutical.